A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors

By Fury Matthew   Solit David   Su Yungpo   Rosen Neal   Sirotnak F.   Smith Robert   Azzoli Christopher   Gomez Jorge   Miller Vincent   Kris Mark   Pizzo Barbara   Henry Roxanne   Pfister David   Rizvi Naiyer  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 467-475

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Trial of Gemcitabine Administered as a 96-h Continuous Intravenous Infusion in Patients with Advanced Carcinoma and Lymphoma

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 369-376

Humana Press, Inc

Access to resources Recommend Favorite

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas

By Feliu J.   Sáenz J.   Jaráiz A.   Castañón C.   Cruz M.   Fonseca E.   Lomas M.   Castro J.   Jara C.   Casado E.   León A.   Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 419-426

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

By Amato Robert   Khan Muhammad  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 1069-1073

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I––II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas

By Lassen Ulrik   Jensen Lars Henrik   Sorensen Morten   Rohrberg Kristoffer S.   Ujmajuridze Zaza   Jakobsen Anders  

Acta Oncologica, Vol. 50, Iss. 3, 2011-04 ,pp. : 448-454

Informa Healthcare

Access to resources Recommend Favorite